Publications by authors named "Fanny Franchini"

Claim this Profile
T
Travel distance and potential disparities in palliative radiotherapy access for cancer patients in Victoria, Australia.
Maike Trommer, Piers Gillett, Fanny Franchini, Karen Trapani, Colin Hornby

Strahlenther Onkol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current and emerging opportunities for deintensification of systemic therapies in melanoma: A scoping review.
Jennifer A Soon, Fanny Franchini, Peter Gourlay, Maarten J IJzerman, Grant A McArthur

Eur J Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Cost Effectiveness of Genomic Medicine in Cancer Control: A Systematic Literature Review.
Mackenzie Bourke, Aideen McInerney-Leo, Julia Steinberg, Tiffany Boughtwood, Vivienne Milch, Fanny Franchini

Appl Health Econ Health Policy· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of risk factors for immune-related adverse events induced by immune checkpoint inhibitor treatment in cancer: A comprehensive systematic review.
Bishma Jayathilaka, Farah Mian, Jo Cockwill, Fanny Franchini, George Au-Yeung

Crit Rev Oncol Hematol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer and treatment specific incidence rates of immune-related adverse events induced by immune checkpoint inhibitors: a systematic review.
Bishma Jayathilaka, Farah Mian, Fanny Franchini, George Au-Yeung, Maarten IJzerman

Br J Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Cancer and treatment specific incidence rates of immune-related adverse events induced by immune checkpoint inhibitors: a systematic review.
Bishma Jayathilaka, Farah Mian, Fanny Franchini, George Au-Yeung, Maarten IJzerman

Br J Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of clinical and socioeconomic factors on Medicare and patient costs for colorectal cancer in Australia: a retrospective multivariate regression analysis.
Ou Yang, Yuting Zhang, Yat Hang To, Maarten M J IJzerman, Judith Liu, Fanny Franchini

BMJ Open· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toward value-based care using cost mining: cost aggregation and visualization across the entire colorectal cancer patient pathway.
Maura Leusder, Sven Relijveld, Derya Demirtas, Jon Emery, Michelle Tew, Fanny Franchini

BMC Med Res Methodol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leveraging the potential for deintensification in cancer care.
Jennifer A Soon, Fanny Franchini, Maarten J IJzerman, Grant A McArthur

Nat Cancer· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting the Population Health Economic Impact of Current and New Cancer Treatments for Colorectal Cancer: A Data-Driven Whole Disease Simulation Model for Predicting the Number of Patients with Colorectal Cancer by Stage and Treatment Line in Australia.
Koen Degeling, Yat Hang To, Karen Trapani, Sophy Athan, Peter Gibbs, Fanny Franchini

Value Health· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Treatment and Outcomes in ALK-Rearranged NSCLC: Results From a Large U.S.-Based Database.
Grace Chazan, Fanny Franchini, Roma Shah, Marliese Alexander, Ani John

JTO Clin Res Rep· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A tailored approach to horizon scanning for cancer medicines.
Jennifer A Soon, Yat Hang To, Marliese Alexander, Karen Trapani, Paolo A Ascierto, Fanny Franchini

J Cancer Policy· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementing competing risks in discrete event simulation: the event-specific probabilities and distributions approach.
Fanny Franchini, Victor Fedyashov, Maarten J IJzerman, Koen Degeling

Front Pharmacol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic review of NTRK 1/2/3 fusion prevalence pan-cancer and across solid tumours.
Sophie O'Haire, Fanny Franchini, Yoon-Jung Kang, Julia Steinberg, Karen Canfell

Sci Rep· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world clinical outcomes and cost estimates of metastatic castration-resistant prostate cancer treatment: does sequencing of taxanes and androgen receptor-targeted agents matter?
Amanda Pereira-Salgado, Angelyn Anton, Fanny Franchini, Robert K Mahar, Edmond M Kwan

Expert Rev Pharmacoecon Outcomes Res· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A scoping review and meta-analysis on the prevalence of pan-tumour biomarkers (dMMR, MSI, high TMB) in different solid tumours.
Yoon-Jung Kang, Sophie O'Haire, Fanny Franchini, Maarten IJzerman, John Zalcberg

Sci Rep· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing Survival Outcomes for Advanced Cancer Patients Who Received Complex Genomic Profiling Using a Synthetic Control Arm.
Sophie O'Haire, Koen Degeling, Fanny Franchini, Ben Tran, Stephen J Luen

Target Oncol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time to diagnosis and treatment of lung cancer: A systematic overview of risk factors, interventions and impact on patient outcomes.
Jianrong Zhang, Maarten J IJzerman, Jasmeen Oberoi, Napin Karnchanachari, Rebecca J Bergin, Fanny Franchini

Lung Cancer· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An inverse stage-shift model to estimate the excess mortality and health economic impact of delayed access to cancer services due to the COVID-19 pandemic.
Koen Degeling, Nancy N Baxter, Jon Emery, Mark A Jenkins, Fanny Franchini

Asia Pac J Clin Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of COVID-19 on cancer service delivery: results from an international survey of oncology clinicians.
Grace Chazan, Fanny Franchini, Marliese Alexander, Susana Banerjee, Linda Mileshkin

ESMO Open· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real world outcomes in KRAS G12C mutation positive non-small cell lung cancer.
Wanyuan Cui, Fanny Franchini, Marliese Alexander, Ann Officer, Hui-Li Wong

Lung Cancer· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FGF2 alters macrophage polarization, tumour immunity and growth and can be targeted during radiotherapy.
Jae Hong Im, Jon N Buzzelli, Keaton Jones, Fanny Franchini, Alex Gordon-Weeks

Nat Commun· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Short Chain Fatty Acid Butyrate Imprints an Antimicrobial Program in Macrophages.
Julie Schulthess, Sumeet Pandey, Melania Capitani, Kevin C Rue-Albrecht, Isabelle Arnold, Fanny Franchini

Immunity· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alpha kinase 1 controls intestinal inflammation by suppressing the IL-12/Th1 axis.
Grigory Ryzhakov, Nathaniel R West, Fanny Franchini, Simon Clare, Nicholas E Ilott

Nat Commun· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Large Polysaccharide Produced by Helicobacter hepaticus Induces an Anti-inflammatory Gene Signature in Macrophages.
Camille Danne, Grigory Ryzhakov, Maria Martínez-López, Nicholas Edward Ilott, Fanny Franchini

Cell Host Microbe· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis